BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang XL, Cai HP, Ge JH, Su XF. Detection of eukaryotic translation initiation factor 4E and its clinical significance in hepatocellular carcinoma. World J Gastroenterol 2012; 18(20): 2540-2544 [PMID: 22654452 DOI: 10.3748/wjg.v18.i20.2540]
URL: https://www.wjgnet.com/1007-9327/full/v18/i20/2540.htm
Number Citing Articles
1
Jun Tu, Yalan Chen, Lili Cai, Changming Xu, Yang Zhang, Yanmei Chen, Chen Zhang, Jian Zhao, Jinke Cheng, Hongwei Xie, Fan Zhong, Fuchu He. Functional Proteomics Study Reveals SUMOylation of TFII-I is Involved in Liver Cancer Cell ProliferationJournal of Proteome Research 2015; 14(6): 2385 doi: 10.1021/acs.jproteome.5b00062
2
Shakur Mohibi, Xinbin Chen, Jin Zhang. Cancer the‘RBP’eutics–RNA-binding proteins as therapeutic targets for cancerPharmacology & Therapeutics 2019; 203: 107390 doi: 10.1016/j.pharmthera.2019.07.001
3
N Robichaud, S V del Rincon, B Huor, T Alain, L A Petruccelli, J Hearnden, C Goncalves, S Grotegut, C H Spruck, L Furic, O Larsson, W J Muller, W H Miller, N Sonenberg. Phosphorylation of eIF4E promotes EMT and metastasis via translational control of SNAIL and MMP-3Oncogene 2015; 34(16): 2032 doi: 10.1038/onc.2014.146
4
Christina Skofler, Florian Kleinegger, Stefanie Krassnig, Anna Maria Birkl-Toeglhofer, Georg Singer, Holger Till, Martin Benesch, Regina Cencic, John A. Porco, Jerry Pelletier, Christoph Castellani, Andrea Raicht, Ewa Izycka-Swieszewska, Piotr Czapiewski, Johannes Haybaeck. Eukaryotic Translation Initiation Factor 4AI: A Potential Novel Target in NeuroblastomaCells 2021; 10(2): 301 doi: 10.3390/cells10020301
5
Jennifer A. Sanders, Philip A. Gruppuso. Translation and Its Regulation in Cancer Biology and Medicine2014; : 611 doi: 10.1007/978-94-017-9078-9_30
6
Xuexia Li, Qiang Zhu, Xiaoliu Shi, Yaxian Cheng, Xueliu Li, Huan Xu, Xiaotao Duan, Linda C. Hsieh-Wilson, Jennifer Chu, Jerry Pelletier, Maowei Ni, Zhiguo Zheng, Sihui Li, Wen Yi. O-GlcNAcylation of core components of the translation initiation machinery regulates protein synthesisProceedings of the National Academy of Sciences 2019; 116(16): 7857 doi: 10.1073/pnas.1813026116
7
Yasmeen Ahmed Salaheldin, Salma Sayed Mohamed Mahmoud, Ebenezeri Erasto Ngowi, Vivian Aku Gbordzor, Tao Li, Dong-Dong Wu, Xin-Ying Ji, Kanhaiya Singh. Role of RONS and eIFs in Cancer ProgressionOxidative Medicine and Cellular Longevity 2021; 2021: 1 doi: 10.1155/2021/5522054
8
Ahmed M Abdelaziz, Mingfeng Yu, Shudong Wang. Mnk inhibitors: a patent reviewPharmaceutical Patent Analyst 2021; 10(1): 25 doi: 10.4155/ppa-2020-0028
9
Nehal S. Abouhashem, Amira Elwan, Noha F. Elaidy. Outcome of Patients With Head and Neck Squamous Cell Carcinoma Can be Predicted by Expression of eIF4E and Osteopontin in Free Surgical MarginsApplied Immunohistochemistry & Molecular Morphology 2022; 30(5): e40 doi: 10.1097/PAI.0000000000001017
10
Jingtao Li, Xianghui Zhang, Le Li, Jinliang Liu, Yanhua Zhang, Hongyu Pan. Proteomics Analysis of SsNsd1-Mediated Compound Appressoria Formation in Sclerotinia sclerotiorumInternational Journal of Molecular Sciences 2018; 19(10): 2946 doi: 10.3390/ijms19102946
11
Mengyan Wu, Yingxia Liu, Xiaoqing Di, Haixian Kang, Hua Zeng, Yi Zhao, Kangrong Cai, Tianyun Pang, Sen Wang, Yunhong Yao, Xinrong Hu. EIF4E over-expresses and enhances cell proliferation and cell cycle progression in nasopharyngeal carcinomaMedical Oncology 2013; 30(1) doi: 10.1007/s12032-012-0400-z
12
Takayuki Kogure, A. Douglas Kinghorn, Irene Yan, Brad Bolon, David M. Lucas, Michael R. Grever, Tushar Patel, Manlio Vinciguerra. Therapeutic Potential of the Translation Inhibitor Silvestrol in Hepatocellular CancerPLoS ONE 2013; 8(9): e76136 doi: 10.1371/journal.pone.0076136
13
Suzana Bracic Tomazic, Christoph Schatz, Johannes Haybaeck. Translational Regulation in Hepatocellular CarcinogenesisDrug Design, Development and Therapy 2021; : 4359 doi: 10.2147/DDDT.S255582
14
Muhammad Umar Ali, Muhammad Saif Ur Rahman, Zhenyu Jia, Cao Jiang. Eukaryotic translation initiation factors and cancerTumor Biology 2017; 39(6): 101042831770980 doi: 10.1177/1010428317709805
15
Yike Yuan, Yaguang Zhang, Shaohua Yao, Huashan Shi, Xi Huang, Yuhao Li, Yuquan Wei, Shuo Lin. The Translation Initiation Factor eIF3i Up-regulates Vascular Endothelial Growth Factor A, Accelerates Cell Proliferation, and Promotes Angiogenesis in Embryonic Development and TumorigenesisJournal of Biological Chemistry 2014; 289(41): 28310 doi: 10.1074/jbc.M114.571356
16
Mamatha Bhat, Akiko Yanagiya, Tyson Graber, Nataliya Razumilava, Steve Bronk, Domenick Zammit, Yunhao Zhao, Chadi Zakaria, Peter Metrakos, Michael Pollak, Nahum Sonenberg, Gregory Gores, Maritza Jaramillo, Masahiro Morita, Tommy Alain. Metformin requires 4E-BPs to induce apoptosis and repress translation of Mcl-1 in hepatocellular carcinoma cellsOncotarget 2017; 8(31): 50542 doi: 10.18632/oncotarget.10671
17
Yongdong Liu, Liling Sun, Xingwang Su, Sien Guo. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinomaBiomedicine & Pharmacotherapy 2016; 84: 237 doi: 10.1016/j.biopha.2016.09.038
18
Nathaniel Robichaud, Nahum Sonenberg. Translation and Its Regulation in Cancer Biology and Medicine2014; : 73 doi: 10.1007/978-94-017-9078-9_4
19
Jun Tan, Jingfen Ye, Meijun Song, Mi Zhou, Yaoren Hu. Ribavirin augments doxorubicin's efficacy in human hepatocellular carcinoma through inhibiting doxorubicin‐induced eIF4E activationJournal of Biochemical and Molecular Toxicology 2018; 32(1) doi: 10.1002/jbt.22007
20
Alessandra Scagliola, Annarita Miluzio, Stefano Biffo. Translational Control of Metabolism and Cell Cycle Progression in Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2023; 24(5): 4885 doi: 10.3390/ijms24054885
21
Xue-Mei Jiang, Xiang-Nan Yu, Ren-Zheng Huang, Hai-Rong Zhu, Xiao-Peng Chen, Ju Xiong, Zheng-Yi Chen, Xiao-Xi Huang, Xi-Zhong Shen, Ji-Min Zhu. Prognostic significance of eukaryotic initiation factor 4E in hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology 2016; 142(11): 2309 doi: 10.1007/s00432-016-2232-2
22
Nicole Golob-Schwarzl, Stefanie Krassnig, Anna M. Toeglhofer, Young Nyun Park, Margit Gogg-Kamerer, Klemens Vierlinger, Fabian Schröder, Hyungjn Rhee, Rudolf Schicho, Peter Fickert, Johannes Haybaeck. New liver cancer biomarkers: PI3K/AKT/mTOR pathway members and eukaryotic translation initiation factorsEuropean Journal of Cancer 2017; 83: 56 doi: 10.1016/j.ejca.2017.06.003
23
Nicole Golob-Schwarzl, Christina Wodlej, Florian Kleinegger, Margit Gogg-Kamerer, Anna Maria Birkl-Toeglhofer, Johannes Petzold, Ariane Aigelsreiter, Michael Thalhammer, Young Nyun Park, Johannes Haybaeck. Eukaryotic translation initiation factor 6 overexpression plays a major role in the translational control of gallbladder cancerJournal of Cancer Research and Clinical Oncology 2019; 145(11): 2699 doi: 10.1007/s00432-019-03030-x
24
Chunmei Wang, Antonio Cigliano, Lijie Jiang, Xiaolei Li, Biao Fan, Maria G. Pilo, Yan Liu, Bing Gui, Marcella Sini, Jeffrey W. Smith, Frank Dombrowski, Diego F. Calvisi, Matthias Evert, Xin Chen. 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N‐Ras proto‐oncogenes in miceHepatology 2015; 61(1): 200 doi: 10.1002/hep.27396